Cisplatin

Cisplatin is an inorganic and water-soluble platinum complex, which is able to inhibit DNA synthesis by conforming DNA adducts.

Catalog No.S1166
5 5 1 Reviews 1 Product Citations
Price Stock Quantity  
USD 97 In stock

Free Overnight Delivery on all orders over $ 500.

Order now and get it on

Cisplatin Chemical Structure

Cisplatin Chemical Structure
Molecular Weight: 300.05

Validation & Quality Control

Product Citations(1)

Customer Reviews(1)

Quality Control & MSDS

Related Compound Libraries

Product Information

  • Compare DNA/RNA Synthesis Inhibitors
    Compare DNA/RNA Synthesis Inhibitors
  • Research Area

Product Description

Biological Activity

Description Cisplatin is an inorganic and water-soluble platinum complex, which is able to inhibit DNA synthesis by conforming DNA adducts.
Targets
IC50
In vitro Cisplatin induces cytotoxic by interaction with DNA to form DNA adducts which activate several signal transduction pathways, including Erk, p53, p73, and MAPK, which culminates in the activation of apoptosis. [1] Cisplatin (30 mM) treated for 6 h induces an apparent activation of Erk in HeLa cells, which is sustained over the following 14 h period. Cisplatin also shows an effective antineoplastic activity by inducing tumor cells death. Cisplatin displays ability to cause renal proximal tubular cell (RPTC) apoptosis, causing cell shrinkage, a 50-fold increase in caspase 3 activity, a 4-fold increase in phosphatidylserine externalization, and 5- and 15-fold increases in chromatin condensation and DNA hypoploidy, respectively. [4] Cisplatin (800 μM) causes typical features of necrosis of RPTC after treatment for 4 hr. [5]
In vivo Cisplatin has been demonstrated to be efficient in regression tumor growth in a wide variety of animal tumors models, including head and neck cancer xenografts, cervical squamous carcinoma xenografts, testicular carcinoma xenografts, ovarian cancer xenografts, breast carcinoma xenografts, colonic carcinoma, heterotransplanted hepatoblastoma, and so on. Cisplatin (5 mg/kg) given weekly i.v. at the day 1 and 7 induces a tumor growth inhibition (GI) of 77.5% and 85.1% of the serous xenografts Ov.Ri(C) and OVCAR-3, respectively. [6]
Clinical Trials A phase III trial of tri-weekly Cisplatin based chemoradiation in locally advanced cervical cancer (TACO) is currently in recruiting.
Features Cisplatin is one of the most widely used and most potent chemotherapy agents.

Protocol(Only for Reference)

Cell Assay: [3]

Cell lines Leukemia L1210/0 cells
Concentrations 7 μg/mL
Incubation Time 2 hours
Method L1210/0 cells are maintained in an exponential suspension culture at 37 ℃ in a humidified atmosphere of 5% CO2 in McCoy's medium 5a (modified), supplemented with 15% calfserum, and Fungizone. L1210/0 cells are incubated in Cisplatin (7 μg/mL) for 2 hr at 37 ℃. To measure growth inhibition, the cells are centrifuged, washed once, resuspended in fresh medium at 30 × 103 to 50 × 103 cells/mL, and incubated for 3 days. Cell numbers are determined on a Coulter Counter. An aliquot of cells is diluted with an equal volume of 0.4% trypan blue. Viability is recorded as the percentage of cells that has excluded trypan blue. Cells incubated with Cisplatin as above are also diluted into 0.1% agar and allowed to grow for 2 weeks when colonies are counted.

Animal Study: [6]

Animal Models The human ovarian cancer xenografts OVCAR-3 in nude mice
Formulation 0.9% NaCl solution
Dosages 5 mg/kg
Administration Given i.v. at day 0 (when tumors had reached a volume between 50 and 150 mm3) and day 7.
1

References

Chemical Information

Download Cisplatin SDF
Molecular Weight (MW) 300.05
Formula

Cl2H6N2Pt

CAS No. 15663-27-1
Synonyms cisplatinum, CDDP, Platinol and Platinol-AQ
Solubility (25°C)
  • DMSO 60 mg/mL
  • Water <1 mg/mL
  • Ethanol <1 mg/mL
Storage 2 years -20°CPowder
2 weeks4°Cin DMSO
6 months-80°Cin DMSO
Chemical Name Platinum, diamminedichloro-, (SP-4-2)-

Research Area

Customer Reviews (1)


Click to enlarge
Rating
Source Dr. Edita Aksamitiene from Thomas Jefferson University. Cisplatin purchased from Selleck
Method Cell viability assay
Cell Lines pancreatic cancer cells
Concentrations 0-1000 nM
Incubation Time 72 h
Results Cisplatin potently inhibited the survival of Capan-2 cells in a dose-dependent manner.

Product Citations (1)

  • Suppression of AKT Anti-Apoptotic Signaling by a Novel Drug Candidate Results in Growth Arrest and Apoptosis of Hepatocellular Carcinoma Cells. [Cuconati A, et al. PLoS One 2013;8(1), e54595]

    PubMed: 23355882

Tech Support & FAQs

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3Monday–Friday 9:00 AM–5:00 PM (Central Time)

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related DNA/RNA Synthesis Inhibitors

  • CCT239065

    CCT239065 is a novel and selective BRAFV600E and LCK inhibitor with IC50 of 13 nM and 6 nM, respectively.

  • Flupirtine maleate

    Flupirtine maleate is the salt form of Flupirtine, which is a non-opioid, centrally acting analgesia, muscle relaxation and neuroprotection.

  • Daphnetin

    Daphnetin is an inhibitor of EGFR, PKA and PKC with IC50 of 7.67 μM, 9.33 μM and 25.01 μM, respectively.

  • NSC-207895 (XI-006)

    NSC-207895 suppresses MDMX with IC50 of 2.5 µM, leading to enhanced p53 stabilization/activation and DNA damage, and also regulate MDM2, an E3 ligase.

  • CX-5461

    CX-5461 selectively inhibits Pol I-driven transcription of rRNA with IC50 of 142 nM in HCT-116 cells.

  • ABT-888 (Veliparib)

    ABT-888 (Veliparib, NSC 737664) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.9 nM, respectively.

  • Olaparib (AZD2281)

    Olaparib (AZD2281, KU0059436) is a selective inhibitor of PARP1 and PARP2 with IC50 of 5 nM and 1 nM, respectively.

  • Iniparib (BSI-201)

    BSI-201 (Iniparib, SAR240550) is a PARP1 inhibitor.

  • KU-55933

    KU-55933 is a potent and specific ATM inhibitor with IC50 and Ki of 13 nM and 2.2 nM, respectively.

  • Rucaparib (AG-014699 , PF-01367338)

    Rucaparib (AG-014699, PF-01367338) is an inhibitor of PARP with Ki of 1.4 nM.

Recently Viewed Items

Tags: buy Cisplatin | Cisplatin ic50 | Cisplatin price | Cisplatin cost | Cisplatin solubility dmso | Cisplatin purchase | Cisplatin manufacturer | Cisplatin research buy | Cisplatin order | Cisplatin mouse | Cisplatin chemical structure | Cisplatin mw | Cisplatin molecular weight | Cisplatin datasheet | Cisplatin supplier | Cisplatin in vitro | Cisplatin cell line | Cisplatin concentration | Cisplatin nmr
Contact Us